- Home
- IMMP vs EXFY Comparison
IMMP vs EXFY Comparison
Compare IMMP & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- EXFY
- Stock Information
- Founded
- IMMP 1987
- EXFY 2008
- Country
- IMMP Australia
- EXFY United States
- Employees
- IMMP N/A
- EXFY N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- EXFY Computer Software: Prepackaged Software
- Sector
- IMMP Health Care
- EXFY Technology
- Exchange
- IMMP Nasdaq
- EXFY Nasdaq
- Market Cap
- IMMP 304.0M
- EXFY 343.4M
- IPO Year
- IMMP N/A
- EXFY 2021
- Fundamental
- Price
- IMMP $1.93
- EXFY $3.40
- Analyst Decision
- IMMP Buy
- EXFY Buy
- Analyst Count
- IMMP 2
- EXFY 4
- Target Price
- IMMP $8.50
- EXFY $3.50
- AVG Volume (30 Days)
- IMMP 98.7K
- EXFY 367.2K
- Earning Date
- IMMP 02-27-2025
- EXFY 02-20-2025
- Dividend Yield
- IMMP N/A
- EXFY N/A
- EPS Growth
- IMMP N/A
- EXFY N/A
- EPS
- IMMP N/A
- EXFY N/A
- Revenue
- IMMP $2,563,302.00
- EXFY $137,440,000.00
- Revenue This Year
- IMMP N/A
- EXFY N/A
- Revenue Next Year
- IMMP $47.79
- EXFY $6.09
- P/E Ratio
- IMMP N/A
- EXFY N/A
- Revenue Growth
- IMMP 9.59
- EXFY N/A
- 52 Week Low
- IMMP $1.66
- EXFY $1.24
- 52 Week High
- IMMP $3.34
- EXFY $4.13
- Technical
- Relative Strength Index (RSI)
- IMMP 42.28
- EXFY 50.68
- Support Level
- IMMP $2.00
- EXFY $3.07
- Resistance Level
- IMMP $2.05
- EXFY $3.68
- Average True Range (ATR)
- IMMP 0.09
- EXFY 0.17
- MACD
- IMMP -0.02
- EXFY -0.04
- Stochastic Oscillator
- IMMP 8.33
- EXFY 54.10
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About EXFY Expensify Inc.
Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.